Literature DB >> 879865

Antibody-mediated cytotoxicity in rheumatoid arthritis.

P E McGill, I Twinn.   

Abstract

Patients with active seropositive rheumatoid arthritis have reduced antibody-mediated cytotoxicity. Synovial fluid lymphocytes have very low cytotoxicity. A relationship appears to exist between disease activity and cytotoxic activity.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 879865      PMCID： PMC1006679          DOI： 10.1136/ard.36.3.268

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  6 in total

1.  Serum factor in rheumatoid arthritis agglutinating sensitized sheep red cells.

Authors:  J BALL
Journal:  Lancet       Date:  1950-11-11       Impact factor: 79.321

Review 2.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

3.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

4.  Characterization of human lymphoid cell-mediated antibody-dependent cytotoxicity (LDAC).

Authors:  E A Calder; S J Urbaniak; W J Penhale; W J Irvine
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

5.  Inhibitory effect of rheumatoid sera on cell damage by lymphocytes.

Authors:  I G Barnett; I C MacLennan
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

6.  Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus.

Authors:  J Schneider; W Chin; G J Friou; S M Cooper; B Harding; R L Hill; F P Quismorio
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330
  6 in total
  7 in total

1.  Lymphocyte studies in rheumatoid arthritis. II. Antibody-mediated and mitogen-induced lymphocyte cytotoxicity in synovial fluid and peripheral blood.

Authors:  V M Corrigall; G S Panayi
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103

2.  NK and K cell activity of human blood: differences according to sex, age, and disease.

Authors:  J Penschow; I R Mackay
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

3.  In-vitro reactions of lymphocytes in rheumatoid arthritis and other rheumatic diseases.

Authors:  K Froebel; R D Sturrock; P Reynolds; A Grennan; A Roxburgh; R N MacSween
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

4.  Antibody-dependent and PHA-induced cellular cytotoxicity in rheumatoid arthritis.

Authors:  J N Rosenberg; H L Currey
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

5.  Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination.

Authors:  P Lewis; B L Hazleman; J R Park; D Y Bulgen; D Franks; C Hurd; D L Brown
Journal:  Clin Rheumatol       Date:  1982-09       Impact factor: 2.980

6.  Antibody dependent cell-mediated cytotoxicity in different forms of rheumatoid arthritis patients.

Authors:  B Misiewicz-Poltorak; M Plachecka-Gutowska
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

7.  Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.

Authors:  F Bortolotti; G Realdi; G Diodati; G Fattovich
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.